Anticipated Shortage

ETOPOSIDE INJECTION

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ETOPOSIDE INJECTION in Canada?

A shortage of ETOPOSIDE INJECTION 20MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 25, 2026), but it has not started yet.

Why is ETOPOSIDE INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will ETOPOSIDE INJECTION be available again?

The manufacturer's estimated resolution date is February 28, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusAnticipated Shortage

Same-ingredient products on file1 product · 0 same form & route

Expected resolution~4 months remaining (estimate)

Affected strength20MG

Report last updated2026-09-25

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

ETOPOSIDE INJECTION

HIKMA CANADA LIMITED

20MG · DIN 02552671

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2027-02-28

~4 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02080036

Strength

20MG

Dosage Form

SOLUTION LIQUID

Route

INTRAVENOUS

Active Ingredient

ETOPOSIDE

Tier

Unrated

Last Updated

2026-09-25

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163